It depends on the condition you want to treat
Discussion The global diabetes epidemic, affecting approximately 828 million adults in 2022 32 , has driven widespread adoption of GLP-1 RAs due to their dual glycemic and weight management benefits 33,34,35
Ozempic (semaglutide), NovoNordisk Mounjaro, Eli Lilly Wegovy (semaglutide) drug label, Food and Drug Administration Tirzepatide versus semaglutide once weekly in patients with Type 2 Diabetes, The New England Journal of Medicine (2021) Once-weekly semaglutide in adults with overweight or obesity, The New England Journal of Medicine (2021) Semaglutide vs tirzepatide for weight loss in adults with overweight or obesity, JAMA Network (2024) Medicare coverage of GLP-1 drugs, Library of Congress (2024) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
But dosing decisions are medical
BAC Water (Bacteriostatic Water) Research Diluent Overview
A patient carrying specific GLP1R variants may benefit from earlier dose escalation, while someone with FTO-risk alleles might experience faster initial appetite suppression